James M. Russell, MD

Article

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

December 15, 2011

Read this meta-analysis of studies examining the efficacy of duloxetine for both painful physical symptoms and depressive illness in patients with mild to moderate major depressive disorder.

Susan G. Ball, Durisala Desaiah, Melissa E. Spann, et al

Original Research

Implications of Pain in Generalized Anxiety Disorder: Efficacy of Duloxetine

June 16, 2008

James T. Hartford, Jean Endicott, Susan G. Kornstein, et al

Original Research

Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies

April 16, 2007

Jean Endicott, James M. Russell, Joel Raskin, et al

Original Research

Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder: Implications for Primary Care Physicians

April 16, 2007

Hannu Koponen, Christer Allgulander, Janelle Erickson, et al

Original Research

Prospective, Long-Term, Multicenter Study of the Naturalistic Outcomes of Patients With Treatment-Resistant Depression

May 15, 2006

David L. Dunner, A. John Rush, James M. Russell, et al

Original Research

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

August 1, 2004

Alan J. Gelenberg, Richard C. Shelton, Paul Crits-Christoph, et al

Original Research

The Cost Consequences of Treatment-Resistant Depression

March 1, 2004

James M. Russell, Kevin Hawkins, Ronald J. Ozminkowski, et al

Original Research

Chronic Depression and Comorbid Personality Disorders: Response to Sertraline Versus Imipramine

May 15, 2003

James M. Russell, Susan G. Kornstein, M. Tracie Shea, et al

Original Research

The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs.

November 1, 2002

William H. Crown, Stan Finkelstein, Ernst R. Berndt, et al

Original Research

Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients

December 31, 1999

Robert M. A. Hirschfeld, Michael H. Allen, Joseph P. McEvoy, et al

Original Research

Predictors of Response to Acute Treatment of Chronic and Double Depression With Sertraline or Imipramine

December 15, 1998

Robert M. A. Hirschfeld, James M. Russell, Pedro L. Delgado, et al

Original Research

The Treatment of Chronic Depression, Part 2: A Double-Blind, Randomized Trial of Sertraline and Imipramine

November 15, 1998

Martin B. Keller, Alan J. Gelenberg, Robert M. A. Hirschfeld, et al

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

Implications of Pain in Generalized Anxiety Disorder: Efficacy of Duloxetine

Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies

Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder: Implications for Primary Care Physicians

Prospective, Long-Term, Multicenter Study of the Naturalistic Outcomes of Patients With Treatment-Resistant Depression

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

The Cost Consequences of Treatment-Resistant Depression

Chronic Depression and Comorbid Personality Disorders: Response to Sertraline Versus Imipramine

The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs.

Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients

Predictors of Response to Acute Treatment of Chronic and Double Depression With Sertraline or Imipramine

The Treatment of Chronic Depression, Part 2: A Double-Blind, Randomized Trial of Sertraline and Imipramine

ELSEWHERE:

FOLLOW US:

James M. Russell, MD

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

Implications of Pain in Generalized Anxiety Disorder: Efficacy of Duloxetine

Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies

Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder: Implications for Primary Care Physicians

Prospective, Long-Term, Multicenter Study of the Naturalistic Outcomes of Patients With Treatment-Resistant Depression

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

The Cost Consequences of Treatment-Resistant Depression

Chronic Depression and Comorbid Personality Disorders: Response to Sertraline Versus Imipramine

The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs.

Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients

Predictors of Response to Acute Treatment of Chronic and Double Depression With Sertraline or Imipramine

The Treatment of Chronic Depression, Part 2: A Double-Blind, Randomized Trial of Sertraline and Imipramine

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles